^
KDR C482R
Clear Cell Renal Cell Carcinoma
crizotinib + pazopanib
Sensitive
:
C3
Onco Targets Ther - 4d
No biomarker
Clear Cell Renal Cell Carcinoma
bevacizumab + pegylated interferon α -2a
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
avelumab + axitinib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
pembrolizumab + axitinib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
sunitinib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
pazopanib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
temsirolimus
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
sorafenib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
lenvatinib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
cabozantinib capsule
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
axitinib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
nivolumab + ipilimumab
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
nivolumab + cabozantinib tablet
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
everolimus
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
bevacizumab
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
pembrolizumab + lenvatinib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
tivozanib
Sensitive
:
A2
PD-L1 expression
Clear Cell Renal Cell Carcinoma
pembrolizumab + axitinib
Sensitive
:
B
VHL mutation
Clear Cell Renal Cell Carcinoma
MK-6482
Sensitive
:
C2
VHL mutation
Clear Cell Renal Cell Carcinoma
PT2385
Sensitive
:
C2
SETD2 mutation
Clear Cell Renal Cell Carcinoma
Immunotherapy
Resistant
:
C3
ERVE-4 expression
Clear Cell Renal Cell Carcinoma
nivolumab
Sensitive
:
C3
SYNE1 mutation
Clear Cell Renal Cell Carcinoma
Immunotherapy
Sensitive
:
C3
HMOX1 expression
Clear Cell Renal Cell Carcinoma
sunitinib
Sensitive
:
C3
CDKN2A mutation
Clear Cell Renal Cell Carcinoma
palbociclib
Sensitive
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our